The Dime: 10/9/2020

Following important cannabis news articles every day can be a real burn-out, we know. That’s why the Emerald rolls up a chronicle of the headiest news hits, and passes them to you at the end of each week. We Bring You: The Dime.

 

Written by Katie Bryan | Emerald Magazine

 

Chronic Pain

A new study from Israel’s Haifa University School of Public Health aimed at assessing the relationship between long‐term medical cannabis (MC) use and cognitive function has impactful results for concerned chronic pain physicians.  The study sample included middle‐ and old-aged chronic pain patients who either abstained or used MC.  Researchers concluded cannabis use does not have a widespread impact on cognition in older chronic pain patients.  According to the researchers cited for the Jerusalem Post, much more research is needed but the results are promising for current and future MC patients.

 

Kush Crop

The cannabis industry is spending millions of dollars in 2020 on lobbyists to facilitate cannabis reform. Both big and small players in the market have made financial contributions in an attempt to sway legislative action. Marijuana Business Daily reported the breakdown of the $3.5 million in spending for the first two quarters of 2020 and the vested interests of each organization’s lobbying endeavors.   

 

Up the Laughing Grass

In a fascinating study conducted at the University of Colorado Hospital, researchers show cannabis users may require more inhaled anesthesia during surgery, an increased level of post-operative pain, and a greater necessity for and volume of pain-relief medication to manage their heightened pain intolerance.  The results were shared at the 2020 annual meeting of the American Society of Anesthesiologists, which was held online due to the national pandemic, as reported by MG Magazine.

Emerald contributor since September 2020

Comments

Your email address will not be published.